NCT06443489View on ClinicalTrials.gov

A Trial of SHR-4849 in Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

June 26, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Advanced Solid Tumors

Interventions

DRUG

SHR-4849

SHR-4849

Trial Locations (1)

Unknown

RECRUITING

Jilin Cancer Hospital, Jilin

All Listed Sponsors

lead

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

INDUSTRY